Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium EPS Diluted (Quarterly) : -0.042 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.042 |
| March 31, 2026 | -0.0552 |
| December 31, 2025 | -0.0411 |
| September 30, 2025 | -0.0648 |
| June 30, 2025 | -0.1607 |
| March 31, 2025 | -0.2432 |
| December 31, 2024 | -0.1634 |
| September 30, 2024 | -0.0002 |
| June 30, 2024 | 0.0128 |
| March 31, 2024 | -0.0775 |
| December 31, 2023 | -0.0666 |
| September 30, 2023 | -0.1064 |
| June 30, 2023 | -0.097 |
| March 31, 2023 | -0.1145 |
| December 31, 2022 | 0.0807 |
| September 30, 2022 | -0.3975 |
| June 30, 2022 | -0.412 |
| Date | Value |
|---|---|
| March 31, 2022 | -1.174 |
| December 31, 2021 | -0.3611 |
| September 30, 2021 | -0.3499 |
| June 30, 2021 | -0.315 |
| March 31, 2021 | -0.329 |
| December 31, 2020 | -0.3606 |
| September 30, 2020 | -0.3086 |
| June 30, 2020 | -0.3652 |
| March 31, 2020 | -0.4462 |
| December 31, 2019 | -0.4353 |
| September 30, 2019 | -0.3461 |
| June 30, 2019 | -0.3493 |
| March 31, 2019 | -0.3424 |
| December 31, 2018 | -0.308 |
| September 30, 2018 | -0.4438 |
| March 31, 2018 | -0.1473 |
| September 30, 2017 | -0.0132 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.693M |
| Total Expenses (Quarterly) | 4.693M |
| Enterprise Value | 23.95M |
| Earnings Yield | -15.99% |
| Normalized Earnings Yield | -15.98 |